Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Ascendis Pharma
Ascendis Pharma
(ASND)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Skytrofa
Lonapegsomatropin
2021-08-25
Growth and development
Skytrofa (previously lonapegsomatropin ascendis pharma)
Lonapegsomatropin
2022-01-11
Growth and development
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lonapegsomatropin
healthy volunteers/patients
,
syndrome
,
turner syndrome
,
gonadal dysgenesis
,
laron syndrome
,
endocrine system diseases
,
pituitary dwarfism
,
pituitary diseases
Palopegteriparatide
endocrine system diseases
,
parathyroid diseases
,
hypoparathyroidism
Gilvetmab
melanoma
Aspartame
healthy volunteers/patients
,
alzheimer disease
,
female genital neoplasms
,
melanoma
,
hepatitis b
,
chronic hepatitis b
,
depression
,
major depressive disorder
,
depressive disorder
,
lung neoplasms
,
triple negative breast neoplasms
,
pancreatic neoplasms
,
neoplasm metastasis
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
chronic hepatitis
,
sickle cell anemia
,
adenocarcinoma
,
sarcoma
,
glioma
,
neuroblastoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
parkinson disease
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
rectal neoplasms
,
covid-19
,
pneumonia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
exanthema
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
neoplasms
,
colorectal neoplasms
,
human influenza
,
non-small-cell lung carcinoma
,
breast neoplasms
,
lupus nephritis
,
nephritis
,
large b-cell lymphoma diffuse
,
anemia
,
leukemia
,
b-cell lymphoma
,
carcinoma
,
non-hodgkin lymphoma
,
myeloid leukemia acute
,
multiple sclerosis
,
sclerosis
,
hepatocellular carcinoma
,
colonic neoplasms
,
thrombocytopenic purpura idiopathic
,
thrombocytopenic purpura
,
purpura
,
liver cirrhosis
,
neuromyelitis optica
,
kidney diseases
,
membranous glomerulonephritis
,
chronic progressive multiple sclerosis
,
myeloid leukemia
,
nephrotic syndrome
,
nephrosis
,
lipoid nephrosis
,
recurrence
,
ovarian neoplasms
,
hemolysis
,
hemolytic anemia autoimmune
,
hemolytic anemia
,
hepatitis
,
hepatitis a
,
arthritis
,
hepatitis c
,
chronic hepatitis c
,
lymphoma
,
rheumatoid arthritis
,
juvenile arthritis
,
follicular lymphoma
,
syndrome
,
hiv infections
,
asthma
,
heart failure
,
myelodysplastic syndromes
,
preleukemia
,
acquired immunodeficiency syndrome
,
kidney transplantation
,
drug-related side effects and adverse reactions
,
heart disease risk factors
,
cognitive dysfunction
Mk3475
renal cell carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
melanoma
,
oncogenes
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use